(Q37819146)

23 August 2017

1 reference

title

Heterophilic chemokine receptor interactions in chemokine signaling and biology (English)

1 reference

23 August 2017

3

0 references

Christian Weber

series ordinal

4

0 references

author name string

Birgit K Kramp

series ordinal

1

1 reference

PubMed ID

21146524

23 August 2017

Alisina Sarabi

series ordinal

2

1 reference

PubMed ID

21146524

23 August 2017

language of work or name

English

0 references

publication date

10 December 2010

1 reference

Experimental Cell Research

23 August 2017

1 reference

23 August 2017

317

1 reference

23 August 2017

5

1 reference

23 August 2017

655-663

1 reference

Chemokines: a new classification system and their role in immunity

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Three-dimensional structures of alpha and beta chemokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Fine-tuning leukocyte responses: towards a chemokine 'interactome'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

A rich chemokine environment strongly enhances leukocyte migration and activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The biological relevance of chemokine-proteoglycan interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

G protein-coupled receptor dimerisation: molecular basis and relevance to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Heterodimerization is required for the formation of a functional GABA(B) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Rhodopsin dimers in native disc membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

CXCR4-CCR5: a couple modulating T cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

A trafficking checkpoint controls GABA(B) receptor heterodimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Chemokine receptor homo- or heterodimerization activates distinct signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Chemokine receptor dimerization: two are better than one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Identification of amino acid residues crucial for chemokine receptor dimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

CXCR7 functions as a scavenger for CXCL12 and CXCL11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Far from the Heart: Receptor cross-talk in remote conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Therapeutic targeting of chemokine interactions in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Ligand-independent CXCR2 dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.014

10.1016/J.YEXCR.2010.11.014

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21146524